Results 81 to 90 of about 385,596 (219)

Environmental Surveillance of Poliovirus in the Democratic Republic of the Congo: Sensitivity and Site Productivity, 2017–2025

open access: yesPathogens
Background: Environmental surveillance (ES) of wastewater was introduced by the Global Polio Eradication Initiative (GPEI) to improve the sensitivity of acute flaccid paralysis (AFP) surveillance.
Vanessa Bakumba-Kiulu   +13 more
doaj   +1 more source

Deconvolving mutational patterns of poliovirus outbreaks reveals its intrinsic fitness landscape

open access: yesNature Communications, 2020
Poliovirus has a higher mutation rate than HIV, yet has been almost eradicated by vaccination while an effective vaccine against HIV does not exist. Here, the authors develop a fitness model for poliovirus viral protein 1 to show that it is subject to ...
Ahmed A. Quadeer   +3 more
doaj   +1 more source

Reactivation of a Bacillus Calmette–Guérin Scar Following Routine Infant Vaccination

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT A 4‐month‐old infant developed erythema and induration at a Bacillus Calmette–Guérin (BCG) scar shortly after routine DTaP‐IPV‐Hib and pneumococcal vaccination. Laboratory findings were normal, and the lesion resolved spontaneously without treatment.
Fatih Demircioğlu   +1 more
wiley   +1 more source

Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya

open access: yesBMC Infectious Diseases, 2009
Background Immunodeficient persons with persistent vaccine-related poliovirus infection may serve as a potential reservoir for reintroduction of polioviruses after wild poliovirus eradication, posing a risk of their further circulation in inadequately ...
Tukei Peter   +9 more
doaj   +1 more source

One-year decline of poliovirus antibodies following fractional-dose inactivated poliovirus vaccine

open access: yes, 2020
Background: Fractional dose (1/5th of full intramuscular dose) of inactivated poliovirus-vaccine administered intradermally (fIPV) is used as IPV dose-sparing strategy.
Kazi, Zaubina   +8 more
core   +1 more source

Growth kinetic analysis of bi-recombinant poliovirus vaccine strains

open access: yes, 2010
Attenuated strains of Sabin poliovirus vaccine replicate in the human gut and in rare cases may cause vaccine-associated paralytic poliomyelitis (VAPP).
Papadi, G.   +15 more
core   +1 more source

Development and Validation of a Quantitative RT-qPCR Panel for the Detection and Monitoring of Polioviruses in Wastewater Samples

open access: yesMicroorganisms
Clusters of acute flaccid paralysis (AFP) caused by oral vaccine-derived poliovirus (VDPV) in 2022 and sporadic outbreaks in New York and Gaza highlight the ongoing risk of polio, alongside the persistent global threat posed by wild-type poliovirus. This
Linnet Immaraj   +8 more
doaj   +1 more source

Survey of national immunization programs and vaccine coverage rates in Asia Pacific countries

open access: yes, 2014
Children in the Asia Pacific region are still suffering from certain vaccine-preventable diseases. The current study surveyed the national immunization programs and vaccine uptake of traditional and newly developed vaccines in 12 countries in this area ...
Lua, Chun-Yi;Santosham, Mathuram   +1 more
core   +1 more source

Determination of Factors Affecting Bivalent (Type 1 and 3) Stability of Oral Poliomyelitis Vaccine

open access: yesMedical Laboratory Journal, 2020
Background and objectives: After using of trivalent oral poliovirus vaccine (OPV) for a long time in Iran, in recent years, due to the eradication of type 2 of poliovirus, a bivalent vaccine containing types 1 and 3 is used.
Sina Soleimani
doaj  

First report of a persistent oropharyngeal infection of type 2 vaccine-derived poliovirus (iVDPV2) in a primary immune deficient (PID) patient after eradication of wild type 2 poliovirus

open access: yesInternational Journal of Infectious Diseases, 2019
This is the first report of persistent oropharyngeal mucosal infection with type 2 poliovirus (iVDPV2) in a primary immune deficient patient (PID) after wild type 2 poliovirus eradication. The iVDPV2 also established persistence in the gut.
Merav Weil   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy